Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127961151 | 12796115 | 1 | I | 20160317 | 20160318 | 20160929 | 20160929 | PER | US-INCYTE CORPORATION-2016IN001737 | INCYTE | 60.39 | YR | F | Y | 68.48000 | KG | 20160929 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127961151 | 12796115 | 1 | PS | JAKAFI | RUXOLITINIB | 1 | Oral | 10 MG, BID | 1403292AA | 0 | 10 | MG | TABLET | BID | |||||
| 127961151 | 12796115 | 2 | SS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | 300 MG | 0 | |||||||||||
| 127961151 | 12796115 | 3 | C | ONDANSETRON | ONDANSETRON | 1 | 4 MG | 0 | |||||||||||
| 127961151 | 12796115 | 4 | C | CARISOPRODOL. | CARISOPRODOL | 1 | 350 MG | 0 | |||||||||||
| 127961151 | 12796115 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 40 MG | 0 | |||||||||||
| 127961151 | 12796115 | 6 | C | HYDROCODONE W/APAP /01554201/ | ACETAMINOPHENHYDROCODONE | 1 | 10 MG -32 | 0 | |||||||||||
| 127961151 | 12796115 | 7 | C | NYSTATIN. | NYSTATIN | 1 | 100000 | 0 | |||||||||||
| 127961151 | 12796115 | 8 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 18 MCG | 0 | |||||||||||
| 127961151 | 12796115 | 9 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 160-4.5 | 0 | |||||||||||
| 127961151 | 12796115 | 10 | C | ESTRADIOL. | ESTRADIOL | 1 | 1 MG | 0 | |||||||||||
| 127961151 | 12796115 | 11 | C | PREDNISONE. | PREDNISONE | 1 | 20 MG | 0 | |||||||||||
| 127961151 | 12796115 | 12 | C | PROMETHAZINE W/CODEINE /01129901/ | 2 | 6.25-10 | 0 | ||||||||||||
| 127961151 | 12796115 | 13 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 1 MG | 0 | |||||||||||
| 127961151 | 12796115 | 14 | C | ANAGRELIDE HCL | 2 | 0.5 MG | 0 | ||||||||||||
| 127961151 | 12796115 | 15 | C | MULTIVITAMINS | VITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127961151 | 12796115 | 2 | Cyst |
| 127961151 | 12796115 | 3 | Product used for unknown indication |
| 127961151 | 12796115 | 4 | Product used for unknown indication |
| 127961151 | 12796115 | 5 | Product used for unknown indication |
| 127961151 | 12796115 | 6 | Product used for unknown indication |
| 127961151 | 12796115 | 7 | Product used for unknown indication |
| 127961151 | 12796115 | 8 | Product used for unknown indication |
| 127961151 | 12796115 | 9 | Product used for unknown indication |
| 127961151 | 12796115 | 10 | Product used for unknown indication |
| 127961151 | 12796115 | 11 | Product used for unknown indication |
| 127961151 | 12796115 | 12 | Product used for unknown indication |
| 127961151 | 12796115 | 13 | Product used for unknown indication |
| 127961151 | 12796115 | 14 | Product used for unknown indication |
| 127961151 | 12796115 | 15 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127961151 | 12796115 | Cough | |
| 127961151 | 12796115 | Cyst | |
| 127961151 | 12796115 | Fatigue | |
| 127961151 | 12796115 | Immunodeficiency | |
| 127961151 | 12796115 | Nausea | |
| 127961151 | 12796115 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127961151 | 12796115 | 1 | 20150318 | 0 |